CS
ORGO icon

Capital Square’s Organogenesis Holdings ORGO Stock Holding History

Capital Square’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.2K Sell
18,813
-300
-2% -$733 0.02% 234
2026
Q1 		$44.9K Buy
19,113
+8,305
+77% +$28.8K 0.02% 221
2025
Q4 		$56K Sell
10,808
-6,202
-36% -$30.1K 0.03% 210
2025
Q3 		$71.8K Sell
17,010
-5,490
-24% -$25.5K 0.04% 199
2025
Q2 		$96.8K Sell
22,500
-600
-3% -$2.24K 0.05% 186
2025
Q1 		$99.8K Buy
23,100
+500
+2% +$2.02K 0.06% 175
2024
Q4 		$80.5K Buy
22,600
+2,000
+10% +$6.71K 0.05% 174
2024
Q3 		$58.9K Buy
20,600
+300
+1% +$841 0.04% 155
2024
Q2 		$61.3K Buy
20,300
+50
+0.2% +$134 0.04% 143
2024
Q1 		$57.5K Sell
20,250
-200
-1% -$680 0.04% 141
2023
Q4 		$83.6K Buy
20,450
+3,930
+24% +$11K 0.09% 95
2023
Q3 		$38.8K Buy
+16,520
New +$52.5K 0.05% 87

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Capital Square's ORGO Position: Q2 2026 in Review

Capital Square reduced its Organogenesis Holdings (ORGO) stake by 1.6% in Q2 2026, selling an estimated $733 and leaving 18,813 shares worth $45.2K. The position accounts for 0.02% of the portfolio, ranked #234.

Capital Square first reported a position in ORGO in Q3 2023 and has held it in 12 quarters since. The position peaked at $99.8K in Q1 2025. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Capital Square held 18,813 shares of Organogenesis Holdings worth $45.2K as of Q2 2026.
  • Capital Square sold 300 Organogenesis Holdings shares in Q2 2026, an estimated $733.
  • Organogenesis Holdings made up 0.02% of Capital Square's portfolio in Q2 2026, its #234 holding.
  • Capital Square first reported a position in Organogenesis Holdings in Q3 2023 and has held it in 12 quarters since.
  • Capital Square's Organogenesis Holdings position peaked at $99.8K in Q1 2025.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Capital Square's 13F filing for Q2 2026, filed 13 Aug 2026.